We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Grocery Outlet
GO
$980M
| $7.38M | ﹤0.01% |
252,670
+528
| +0.2% | +$16.6K |
|
1652
Codexis
CDXS
$158M
| $7.37M | ﹤0.01% |
1,581,088
+174,311
| +12% | +$956K |
|
1653
First Commonwealth Financial
FCF
$2.17B
| $7.36M | ﹤0.01% |
526,664
+199,107
| +61% | +$2.8M |
|
|
DCH
1654
Dauch Corp
DCH
$1.51B
| $7.33M | ﹤0.01% |
937,905
-270,595
| -22% | -$2.42M |
|
1655
Trinity Industries
TRN
$2.38B
| $7.33M | ﹤0.01% |
247,792
-37,700
| -13% | -$1.05M |
|
1656
Standex International
SXI
$4.12B
| $7.31M | ﹤0.01% |
71,384
-21,408
| -23% | -$2.1M |
|
1657
ICU Medical
ICUI
$4.61B
| $7.3M | ﹤0.01% |
46,364
-1,208
| -3% | -$184K |
|
1658
Moelis & Co
MC
$4.94B
| $7.3M | ﹤0.01% |
190,196
-35,054
| -16% | -$1.42M |
|
1659
MillerKnoll
MLKN
$1.67B
| $7.3M | ﹤0.01% |
347,290
-25,228
| -7% | -$505K |
|
1660
FormFactor
FORM
$9.17B
| $7.29M | ﹤0.01% |
327,937
-11,919
| -4% | -$278K |
|
1661
Leslie's
LESL
$11M
| $7.28M | ﹤0.01% |
29,817
+1,037
| +4% | +$288K |
|
1662
SunCoke Energy
SXC
$797M
| $7.28M | ﹤0.01% |
843,368
+544,738
| +182% | +$4.21M |
|
1663
Green Plains
GPRE
$1.03B
| $7.27M | ﹤0.01% |
238,406
-15,652
| -6% | -$482K |
|
1664
Brighthouse Financial
BHF
$3.5B
| $7.25M | ﹤0.01% |
141,498
-35,979
| -20% | -$1.88M |
|
1665
Ethan Allen Interiors
ETD
$603M
| $7.25M | ﹤0.01% |
274,317
+10,939
| +4% | +$282K |
|
|
WSR
1666
DELISTED
Whitestone REIT
WSR
| $7.25M | ﹤0.01% |
751,693
+65,856
| +10% | +$606K |
|
|
ECHO
1667
EchoStar
ECHO
$26.2B
| $7.21M | ﹤0.01% |
432,277
-35,463
| -8% | -$615K |
|
|
BRKL
1668
DELISTED
Brookline Bancorp
BRKL
| $7.21M | ﹤0.01% |
509,466
+219,769
| +76% | +$2.94M |
|
|
MRSN
1669
DELISTED
Mersana Therapeutics
MRSN
| $7.2M | ﹤0.01% |
49,176
-1,589
| -3% | -$269K |
|
1670
Vishay Precision Group
VPG
$914M
| $7.17M | ﹤0.01% |
185,430
+12,766
| +7% | +$465K |
|
1671
TG Therapeutics
TGTX
$7.62B
| $7.16M | ﹤0.01% |
605,147
+83,118
| +16% | +$603K |
|
1672
AeroVironment
AVAV
$9.45B
| $7.15M | ﹤0.01% |
83,467
+2,543
| +3% | +$217K |
|
1673
CONMED
CNMD
$1.47B
| $7.15M | ﹤0.01% |
80,659
-5,866
| -7% | -$487K |
|
1674
Metropolitan Bank Holding Corp
MCB
$1.15B
| $7.13M | ﹤0.01% |
121,475
+4,867
| +4% | +$308K |
|
1675
Castle Biosciences
CSTL
$979M
| $7.12M | ﹤0.01% |
302,649
+191,974
| +173% | +$4.45M |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.